Cargando…

Systemic overuse of health care in a commercially insured US population, 2010–2015

BACKGROUND: Overuse is a leading contributor to the high cost of health care in the United States. Overuse harms patients and is a definitive waste of resources. The Johns Hopkins Overuse Index (JHOI) is a normalized measure of systemic health care services overuse, generated from claims data, that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oakes, Allison H., Chang, Hsien-Yen, Segal, Jodi B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498548/ https://www.ncbi.nlm.nih.gov/pubmed/31046746 http://dx.doi.org/10.1186/s12913-019-4079-0

Ejemplares similares

Changing patterns of use of implantable cardiac monitors from 2011 to 2018 for a large commercially-insured U.S. population
por: Ellenbogen, Michael I., et al.
Publicado: (2021)

Factors Associated With Overuse of Health Care Within US Health Systems: A Cross-sectional Analysis of Medicare Beneficiaries From 2016 to 2018
por: Segal, Jodi B., et al.
Publicado: (2022)

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020
por: Busse, Clara E., et al.
Publicado: (2023)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
por: Funch, Donnie, et al.
Publicado: (2019)

The Association between NICU Admission and Mental Health Diagnoses among Commercially Insured Postpartum Women in the US, 2010–2018
por: Beck, Dana C., et al.
Publicado: (2022)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Antidepressants overuse in primary care: prescription trends between 2010-2019 in Catalonia
por: Gonzalez, M. S., et al.
Publicado: (2023)

Care Among Migraine Patients in a Commercially Insured Population
por: Bonafede, Machaon, et al.
Publicado: (2020)

Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
por: Whaley, Christopher M., et al.
Publicado: (2020)

The impact of a regional patient-centered medical home initiative on cost of care among commercially insured population in the US
por: Maeng, Daniel Dukjae, et al.
Publicado: (2016)

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population
por: Kappelman, Michael D., et al.
Publicado: (2012)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Trends in Infertility Care Among Commercially Insured US Women During the COVID-19 Pandemic
por: Zhou, Beth, et al.
Publicado: (2021)

Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population
por: Nguyen, Christina A., et al.
Publicado: (2019)

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
por: Giles, Jon T., et al.
Publicado: (2021)

Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
por: Plummer, Elizabeth, et al.
Publicado: (2022)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

660. Are US Clinicians Thinking Measles in the Post-elimination Era? Surveillance for Measles-Like Illness in a Commercially Insured US Population
por: McKay, Susannah, et al.
Publicado: (2018)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
por: Kern, David M, et al.
Publicado: (2015)

Utilization patterns and characteristics of users of biologic anti‐inflammatory agents in a large, US commercially insured population
por: Mendelsohn, Aaron B., et al.
Publicado: (2020)

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population
por: Funch, Donnie, et al.
Publicado: (2021)

Insurance Coverage and Perinatal Health Care Use Among Low-Income Women in the US, 2015-2017
por: Admon, Lindsay K., et al.
Publicado: (2021)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
por: McLaurin, Kimmie K, et al.
Publicado: (2019)

Ambulatory Health Care Service Use and Costs Among Commercially Insured US Adults With Congenital Heart Disease
por: Agarwal, Anushree, et al.
Publicado: (2020)

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)

Data on U.S. state-level electric vehicle policies, 2010–2015
por: Wee, Sherilyn, et al.
Publicado: (2019)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Cesarean overuse and the culture of care
por: White VanGompel, Emily, et al.
Publicado: (2019)

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
por: Wallace, Beth I., et al.
Publicado: (2021)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m821c5o7beh7gd3fcogipo3ju5